Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-100221
Filing Date
2024-08-23
Accepted
2024-08-23 16:35:07
Documents
13
Period of Report
2024-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A hcwb-20240814.htm   iXBRL 8-K/A 48292
2 EX-99.1 hcwb-ex99_1.htm EX-99.1 144796
3 GRAPHIC img90053791_0.jpg GRAPHIC 46853
  Complete submission text file 0000950170-24-100221.txt   396568

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20240814.xsd EX-101.SCH 28181
15 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20240814_htm.xml XML 6018
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40591 | Film No.: 241236773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)